The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo
Bcl-2/Bcl-X(L)/Bcl-w 抑制剂 navitoclax 可增强化疗药物在体内和体外的活性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-11-0415
Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard Liu, Michael J Mitten, Paul Nimmer, Xiaoyu Lin, Morey Smith, Yu Shen, Alexander R Shoemaker, Stephen K Tahir, Haichao Zhang, Scott L Ackler, Saul H Rosenberg, Heather Maecker, Deepak Sampath, Joel D Leverson, Chris Tse, Steven W Elmore
